Log in

Preparation and evaluation of a new neurotensin analog labeled with 99mTc for targeted imaging of neurotensin receptor positive tumors

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

Neurotensin receptors are overexpressed in several human tumors and can be targets for tumors diagnosis and therapy. In this study, a new neurotensin analogue was labeled with 99mTc via HYNIC and tricine/EDDA as coligands and investigated further. [HYNIC0, Gly7, Lys9, d-Tyr11]-Neurotensin (7–13) was synthesized using a standard Fmoc strategy. Labeling with 99mTc was performed at 100 °C for 10 min and radiochemical analysis involved ITLC and HPLC methods. The stability of radiopeptide was checked in the presence of humane serum at 37 °C up to 24 h. The receptor bound internalization and externalization rates were studied in neurotensin receptor expressing HT-29 cells. Biodistribution of radiopeptide was studied in nude mice bearing HT-29 tumor. Labeling yield of 98.6 ± 0.54 % (n = 3) was obtained corresponding to a specific activity of 81 MBq/nmol. Peptide conjugate showed good stability in the presence of human serum. The radioligand showed specific internalization into HT-29 cells (12.43 ± 0.52 % at 4 h). In biodistribution studies, a receptor-specific uptake was observed in neurotensin receptor positive organs so that after 1 h the uptakes in mouse intestine and tumor were 0.87 ± 0.16 and 0.63 ± 0.12 % ID/g respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Reubi JC (1995) J Nucl Med 36:1825

    CAS  Google Scholar 

  2. Okarvi SM (2004) Med Res Rev 24(3):357

    Article  CAS  Google Scholar 

  3. Hoffman TJ, Quinn TP, Volkert WA (2001) Nucl Med Biol 28(5):527

    Article  CAS  Google Scholar 

  4. Reubi JC (2003) Endocr Rev 24:389

    Article  CAS  Google Scholar 

  5. Morinville A, Martin S, Lavallee M, Vincent JP, Beaudet A, Mazella J (2004) Int J Biochem Cell Biol 36:2153

    Article  CAS  Google Scholar 

  6. Kitabgi P (2002) Curr Opin Drug Discov Devel 5:764

    CAS  Google Scholar 

  7. Vincent JP, Mazella J, Kitabgi P (1999) Trends Pharmacol Sci 20:302

    Article  CAS  Google Scholar 

  8. Reubi JC, Maecke HR, Krenning EP (2005) J Nucl Med 46:67

    Google Scholar 

  9. Reubi JC, Waser B, Friess H, Buchler M, Laissue J (1998) Gut 42:546

    Article  CAS  Google Scholar 

  10. Achilefu S, Srinivasan A, Schmidt MA, Jimenez HN, Bugaj JE, Erion JL (2003) J Med Chem 46:3403

    Article  CAS  Google Scholar 

  11. Garcia-Garayoa E, Allemann-Tannahill L, Blauenstein P, Willmann M, Carell-remy N, Tourwe D, Iterbeke K, Conrath P, Schubiger PA (2001) Nucl Med Biol 28:75

    Article  CAS  Google Scholar 

  12. Kokko KP, Hadden MK, Orwig KS, Mazella J, Dix TA (2003) J Med Chem 46:4141

    Article  CAS  Google Scholar 

  13. Lundquist JT, Dix TA (1999) Biorg Med Chem Lett 9:2579

    Article  CAS  Google Scholar 

  14. Hong F, Zaidi J, Cusack B, Richelson E (2002) Bioorg Med Chem 10:3849

    Article  CAS  Google Scholar 

  15. Kitabgi P, De Nadai F, Rovere C, Bidard JN (1992) Ann N Y Acad Sci 668:30

    Article  CAS  Google Scholar 

  16. Davis TP, Konings PNM (1993) Crit Rev Neurobiol 7:163

    CAS  Google Scholar 

  17. Garcıa-Garayoa E, Maes V, Blauenstein P, Blanc A, Hohn A, Tourwe D, Schubiger PA (2006) Nucl Med Biol 33:495

    Article  Google Scholar 

  18. Heyl D, Sefler NM, He JX, Sawyer TK, Wustrow DJ, Akunne HC, Davis MD, Pugsley TP, Heffner TG, Corbin AE, Cody WL (1994) Chem Biol Drug Des 44:233

    CAS  Google Scholar 

  19. Hoffman TJ, Gali H, Smith VJ, Siekman GL, Hayes DL, Owen NK, Volkert WA (2003) J Nucl Med 44:823

    CAS  Google Scholar 

  20. Bergmann R, Scheunemann M, Heichert C, Mding P, Wittrisch H, Kretzschmar M, Rodig H, Tourwe D, Iterbeke K, Chavatte K, Zips D, Reubi JC, Johannsen B (2002) Nucl Med Biol 29:61

    Article  CAS  Google Scholar 

  21. Hoffman TJ, Li N, Volkert WA, Sieckman GL, Higginbotham C, Ochrymowcycz LA (1997) J Label Compd Radiopharm 40:490

    Google Scholar 

  22. Garcıa-Garayoa E, Blauenstein P, Blanc A, Maes V, Tourwe D, Schubiger PA (2009) Eur J Nucl Med Mol Imaging 36(1):37

    Google Scholar 

  23. Schubiger PA, Allemann-Tannahill L, Egli A, Schibli R, Alberto R, Carel-Remy N, Willmann M, Blauenstein P, Tourwe D (1999) Q J Nucl Med Mol Imaging 43:155

    CAS  Google Scholar 

  24. Teodoro R, Faintuch BL, Nunez EGF, Queiroz RG (2011) Nucl Med Biol 38:113

    Article  CAS  Google Scholar 

  25. Maina T, Nikolopoulou A, Stathopoulou E, Galanis AS, Cordopatis P, Nock BA (2007) Eur J Nucl Med Mol Imaging 34:1804

    Article  CAS  Google Scholar 

  26. Abrams MJ, Juweid M, tenKate CI, Schwartz DA, Hauser MM, Gaul FE, Fuccello AJ, Rubin RH, Strauss W, Fischman AJ (1990) J Nucl Med 31:2022

    CAS  Google Scholar 

  27. Faintuch BL, Santos RLSR, Souza ALFM, Hoffman TJ, Greeley M, Smith CJ (2005) Chemistry 35:43

    CAS  Google Scholar 

  28. Gandomkar M, Najafi R, Shafiei M, Mazidi M, Ebrahimi SES (2007) Nucl Med Biol 34:651

    Article  CAS  Google Scholar 

  29. Sadeghzadeh N, Gandomkar M, Najafi R, Shafiei M, Sadat Ebrahimi SE, Shafiee A, Larijani B (2010) J Radioanal Nucl Chem 283:181

    Article  CAS  Google Scholar 

  30. Sadeghzadeh N, Gandomkar M, Shafiee M, Mazidi M, Goudarzi M, Mirfallah SM, Sadat Ebrahimi SE (2009) Iran J Nucl Med 17(1):18

    CAS  Google Scholar 

  31. Atherton E, Sheppard R (1989) Fluorenylmethoxycarbonyl-poly-amide solid phase peptide synthesis—general principles and development. In: Solid phase peptide synthesis. A practical approach, Oxford Information Press, Oxford, p 25–38

  32. Maina T, Nock B, Nikolopoulou A (2002) Eur J Nucl Med Mol Imaging 29:742

    Article  CAS  Google Scholar 

  33. Erfani M, Shafiei M, Mazidi M, Goudarzi M (2013) Cancer Biother Radiopharm 28(3):240

    Article  CAS  Google Scholar 

  34. Shirmardi SP, Gandomkar M, Mazidi M, Shafiei M, Ghannadi Maragheh M (2011) J Radioanal Nucl Chem 288:327

    Article  CAS  Google Scholar 

  35. Shirmardi SP, Gandomkar M, Ghannadi Maragheh M, Shamsaei M (2011) Cancer Biother Radiopharm 26(3):309

    Article  CAS  Google Scholar 

  36. Liu S, Edwards DS, Looby RJ, Poirier MJ, Rajopadhye M, Bourque JP, Carroll TR (1996) Bioconjug Chem 7(2):196

    Article  CAS  Google Scholar 

  37. Kasina S, Rao T, Srinivasan A, Sanderson JA, Fitzner JN, Reno JM, Beaumier PL, Fritzberg AR (1991) J Nucl Med 32:1445

    CAS  Google Scholar 

  38. Maina T, Stolz B, Albert R, Bruns C, Koch P, Maecke HR (1994) Eur J Nucl Med 21(5):437

    Article  CAS  Google Scholar 

  39. Yurt Lambrecht F, Durkan K, Ozgur A, Gunduz C, Avci CB, Susluer SY (2013) J Drug Target 21(4):383

    Article  Google Scholar 

  40. Yurt Lambrecht F, Durkan K, Bayrak E (2010) J Radioanal Nucl Chem 284:539

    Article  CAS  Google Scholar 

  41. Liu S, Edwards DS, Looby RJ, Harris AR, Poirier MJ, Barrett JA, Heminway SJ, Carrol TR (1996) Bioconj Chem 7:63

    Article  CAS  Google Scholar 

  42. Gabriel M, Froehlich F, Decristoforo C, Ensinger C, Donnemiller E, von Guggenberg E, Heute D, Moncayo R (2004) Eur J Nucl Med Mol Imaging 31:330

    Article  CAS  Google Scholar 

  43. Babich JW, Fischman AJ (1995) Nucl Med Biol 22(1):25

    Article  CAS  Google Scholar 

  44. Nock BA, Nikolopoulou A, Reubi JC, Maes V, Conrath P, Tourwe D, Maina T (2006) J Med Chem 49:4767

    Article  CAS  Google Scholar 

  45. Tanaka K, Masu M, Nakanishi S (1996) Neuron 4:847

    Article  Google Scholar 

  46. Mule F, Serio R, Postorino A, Vetri T, Bonvissuto F (1996) Br J Pharmacol 117:488

    Article  CAS  Google Scholar 

  47. Bidard JN, Nadai F, Rovere C, Moinier D, Laur J, Martinez J, Cuber JC, Kitabgi P (1993) Biochem J 291:225

    CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Mr. Mirfallah and Mr. Talebi of the Radioisotope Department (AEOI) for providing sodium pertechnetate and assistance in quality control tests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nakisa Zarrabi Ahrabi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahrabi, N.Z., Erfani, M., Parivar, K. et al. Preparation and evaluation of a new neurotensin analog labeled with 99mTc for targeted imaging of neurotensin receptor positive tumors. J Radioanal Nucl Chem 299, 461–469 (2014). https://doi.org/10.1007/s10967-013-2795-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10967-013-2795-1

Keywords

Navigation